Status:
TERMINATED
Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Coronary artery disease results in narrowing of the blood vessels supplying oxygenated blood to the heart muscle. Diagnosis in patients with symptoms of chest pain is now quickly done with CT coronary...
Detailed Description
The Investigators and others have demonstrated direct imaging of myocardial ischemia using 18F-Fluorodeoxyglucose (18FDG) with exercise or dipyridamole stress and positron emission tomography (PET) or...
Eligibility Criteria
Inclusion
- Patients with suspected CAD referred for CTA and found to have moderate CAD stenoses and 20 normal volunteers with less than 5% probability of CAD.
- Age ≥ 18 years
Exclusion
- Inability to undergo stress protocol due to co-morbidities
- Pregnancy
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01520025
Start Date
December 1 2011
End Date
January 1 2015
Last Update
April 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y 4W7